Stocks
AbbVie (ABBV) R&D/CAPEX US GAAP (year values) |
|||||||||
| 2019 | 2020 | 2021 | 2022 | 2023 | LTM ? | CAGR 5 years ? | |||
| R&D/CAPEX, % | 1 161% | 821.7% | 900.1% | 936.7% | 1 088% | 1 142% | |||
| Changes by years, y/y, % | -458pp | -339pp | +78pp | +37pp | +151pp | -7.6% | |||
AbbVie. R&D/CAPEX, %
AbbVie. R&D/CAPEX, changes, pp
AbbVie (ABBV) R&D/CAPEX US GAAP (quarter values) |
||||||||
| 2023Q4 | 2024Q1 | 2024Q1 | 2024Q2 | 2024Q3 | LTM ? | |||
| R&D/CAPEX, % | 937.1% | 1 005% | 795.4% | 855.4% | 1 142% | |||
| Changes by years, y/y, % | +97pp | -1 310pp | -305pp | -178pp | +69pp | |||
| Changes by quarters, q/q, % | +150pp | -937pp | -209pp | +60pp | ||||
